News
PASADENA, Calif., July 08, 2025--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subject in the YOSEMITE Phase 3 clinical trial of zodasiran, the company ...
Biogen initiates phase 3 study of felzartamab in kidney disease patients Approximately 36,000 people in the US are affected by primary membranous nephropathy Biogen has announced that it has initiated ...
Ultragenyx is developing setrusumab in pediatric and young adult patients across OI sub-types I, III and IV with two late-stage studies: the pivotal Phase 2/3 Orbit study and Phase 3 Cosmic study.
Denmark international Marcus Möller has committed to play college basketball future for Michigan, which generated a buzz among college hoops fans.
An antisense drug in development at GSK has shown further activity against hepatitis B virus (HBV) in a mid-stage trial, setting up a phase 3 assessment next year to see if it could offer a ...
Bayer is pressing ahead with a phase 3 trial of its oral Factor XIa inhibitor asundexian, a new anticoagulant, despite missing efficacy targets in two mid-stage studies.
Tonix Pharmaceuticals has announced the publication of its Phase 3 RESILIENT trial results for TNX-102 SL, a sublingual formulation of cyclobenzaprine for treating fibromyalgia.
A panel of experts has recommended the government phase out buy-outs for homeowners whose properties are damaged by extreme weather events.
LEXINGTON, Mass., July 07, 2025--Agenus Inc. (Nasdaq: AGEN) a leader in immuno-oncology innovation, today announced that its botensilimab and balstilimab (BOT/BAL) combination achieved a two-year ...
The Wimbledon quarterfinals wrapped up today — here's what happened.
City Manager Tommy Eaton visited Ada Sunrise Rotary Club on Friday to bring updates from the City of Ada.
Beacon noted that its phase 2 DAWN trial continues to progress, and the company released 6-month interim safety and efficacy results in May 2025. 3 According to the company, laru-zova was generally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results